Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 187,288 $ 187,353
Short-term restricted cash 1,051 982
Short-term investments 0 18,529
Accounts receivable, net 170,619 170,971
Inventory 99,908 160,544
Prepaid expenses and other current assets 29,159 24,745
Total current assets 488,025 563,124
Long-term restricted cash 17 22
Property and equipment, net 66,431 79,018
Leased right-of-use assets 31,264 28,515
Intangible assets, net 73,630 109,316
Goodwill 318,588 306,739
Deferred tax assets 69,493 66,491
Other long-term assets 32,809 26,800
Total assets 1,080,257 1,180,025
Current liabilities:    
Accounts payable 21,551 68,576
Accrued price protection liability 71,684 113,274
Accrued expenses and other current liabilities 98,468 100,155
Accrued compensation 30,426 59,081
Total current liabilities 222,129 341,086
Long-term lease liabilities 26,243 23,353
Long-term debt 122,375 121,757
Other long-term liabilities 23,245 17,444
Total liabilities 393,992 503,640
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.0001 par value; 550,000 shares authorized; 81,818 shares issued and outstanding at December 31, 2023 and 78,745 shares issued and outstanding December 31, 2022 8 8
Additional paid-in capital 808,575 722,778
Accumulated other comprehensive loss (3,791) (1,021)
Accumulated deficit (118,527) (45,380)
Total stockholders’ equity 686,265 676,385
Total liabilities and stockholders’ equity $ 1,080,257 $ 1,180,025